[1]
Arcellana, A.E. et al. 2021. THE USE OF MULTIMODALITY TREATMENT FOR AN ATYPICAL, RECURRENT AND AGGRESSIVE MEDULLARY THYROID CANCER. Journal of the ASEAN Federation of Endocrine Societies. 36, (Jul. 2021), 4. DOI:https://doi.org/10.15605/jafes.036.S4.